Cargando…
Network Pharmacology-Based Strategy to Investigate the Pharmacological Mechanisms of Ginkgo biloba Extract for Aging
Aging is a main risk factor for a number of debilitating diseases and contributes to an increase in mortality. Previous studies have shown that Ginkgo biloba extract (EGb) can prevent and treat aging-related diseases, but its pharmacological effects need to be further clarified. This study aimed to...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403930/ https://www.ncbi.nlm.nih.gov/pubmed/32802136 http://dx.doi.org/10.1155/2020/8508491 |
_version_ | 1783567038640291840 |
---|---|
author | Liu, Yanfei Liu, Yue Zhang, Wantong Sun, Mingyue Weng, Weiliang Gao, Rui |
author_facet | Liu, Yanfei Liu, Yue Zhang, Wantong Sun, Mingyue Weng, Weiliang Gao, Rui |
author_sort | Liu, Yanfei |
collection | PubMed |
description | Aging is a main risk factor for a number of debilitating diseases and contributes to an increase in mortality. Previous studies have shown that Ginkgo biloba extract (EGb) can prevent and treat aging-related diseases, but its pharmacological effects need to be further clarified. This study aimed to propose a network pharmacology-based method to identify the therapeutic pathways of EGb for aging. The active components of EGb and targets of sample chemicals were obtained from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) database. Information on aging-related genes was obtained from the Human Ageing Genomic Resources database and JenAge Ageing Factor Database. Subsequently, a network containing the interactions between the putative targets of EGb and known therapeutic targets of aging was established, which was used to investigate the pharmacological mechanisms of EGb for aging. A total of 24 active components, 154 targets of active components of EGb, and 308 targets of aging were obtained. Network construction and pathway enrichment were conducted after data integration. The study found that flavonoids (quercetin, luteolin, and kaempferol) and beta-sitosterol may be the main active components of EGb. The top eight candidate targets, namely, PTGS2, PPARG, DPP4, GSK3B, CCNA2, AR, MAPK14, and ESR1, were selected as the main therapeutic targets of EGb. Pathway enrichment results in various pathways were associated with inhibition of oxidative stress, inhibition of inflammation, amelioration of insulin resistance, and regulation of cellular biological processes. Molecular docking results showed that PPARG had better binding capacity with beta-sitosterol, and PTGS2 had better binding capacity with kaempferol and quercetin. The main components of EGb may act on multiple targets, such as PTGS2, PPARG, DPP4, and GSK3B, to regulate multiple pathways, and play an antiaging role by inhibiting oxidative stress, inhibiting inflammation, and ameliorating insulin resistance. |
format | Online Article Text |
id | pubmed-7403930 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-74039302020-08-14 Network Pharmacology-Based Strategy to Investigate the Pharmacological Mechanisms of Ginkgo biloba Extract for Aging Liu, Yanfei Liu, Yue Zhang, Wantong Sun, Mingyue Weng, Weiliang Gao, Rui Evid Based Complement Alternat Med Research Article Aging is a main risk factor for a number of debilitating diseases and contributes to an increase in mortality. Previous studies have shown that Ginkgo biloba extract (EGb) can prevent and treat aging-related diseases, but its pharmacological effects need to be further clarified. This study aimed to propose a network pharmacology-based method to identify the therapeutic pathways of EGb for aging. The active components of EGb and targets of sample chemicals were obtained from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) database. Information on aging-related genes was obtained from the Human Ageing Genomic Resources database and JenAge Ageing Factor Database. Subsequently, a network containing the interactions between the putative targets of EGb and known therapeutic targets of aging was established, which was used to investigate the pharmacological mechanisms of EGb for aging. A total of 24 active components, 154 targets of active components of EGb, and 308 targets of aging were obtained. Network construction and pathway enrichment were conducted after data integration. The study found that flavonoids (quercetin, luteolin, and kaempferol) and beta-sitosterol may be the main active components of EGb. The top eight candidate targets, namely, PTGS2, PPARG, DPP4, GSK3B, CCNA2, AR, MAPK14, and ESR1, were selected as the main therapeutic targets of EGb. Pathway enrichment results in various pathways were associated with inhibition of oxidative stress, inhibition of inflammation, amelioration of insulin resistance, and regulation of cellular biological processes. Molecular docking results showed that PPARG had better binding capacity with beta-sitosterol, and PTGS2 had better binding capacity with kaempferol and quercetin. The main components of EGb may act on multiple targets, such as PTGS2, PPARG, DPP4, and GSK3B, to regulate multiple pathways, and play an antiaging role by inhibiting oxidative stress, inhibiting inflammation, and ameliorating insulin resistance. Hindawi 2020-07-27 /pmc/articles/PMC7403930/ /pubmed/32802136 http://dx.doi.org/10.1155/2020/8508491 Text en Copyright © 2020 Yanfei Liu et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Liu, Yanfei Liu, Yue Zhang, Wantong Sun, Mingyue Weng, Weiliang Gao, Rui Network Pharmacology-Based Strategy to Investigate the Pharmacological Mechanisms of Ginkgo biloba Extract for Aging |
title | Network Pharmacology-Based Strategy to Investigate the Pharmacological Mechanisms of Ginkgo biloba Extract for Aging |
title_full | Network Pharmacology-Based Strategy to Investigate the Pharmacological Mechanisms of Ginkgo biloba Extract for Aging |
title_fullStr | Network Pharmacology-Based Strategy to Investigate the Pharmacological Mechanisms of Ginkgo biloba Extract for Aging |
title_full_unstemmed | Network Pharmacology-Based Strategy to Investigate the Pharmacological Mechanisms of Ginkgo biloba Extract for Aging |
title_short | Network Pharmacology-Based Strategy to Investigate the Pharmacological Mechanisms of Ginkgo biloba Extract for Aging |
title_sort | network pharmacology-based strategy to investigate the pharmacological mechanisms of ginkgo biloba extract for aging |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403930/ https://www.ncbi.nlm.nih.gov/pubmed/32802136 http://dx.doi.org/10.1155/2020/8508491 |
work_keys_str_mv | AT liuyanfei networkpharmacologybasedstrategytoinvestigatethepharmacologicalmechanismsofginkgobilobaextractforaging AT liuyue networkpharmacologybasedstrategytoinvestigatethepharmacologicalmechanismsofginkgobilobaextractforaging AT zhangwantong networkpharmacologybasedstrategytoinvestigatethepharmacologicalmechanismsofginkgobilobaextractforaging AT sunmingyue networkpharmacologybasedstrategytoinvestigatethepharmacologicalmechanismsofginkgobilobaextractforaging AT wengweiliang networkpharmacologybasedstrategytoinvestigatethepharmacologicalmechanismsofginkgobilobaextractforaging AT gaorui networkpharmacologybasedstrategytoinvestigatethepharmacologicalmechanismsofginkgobilobaextractforaging |